BloodSTAR is an online system used in all States and Territories (except NSW) to manage access to the supply of government funded immunoglobulin products. The system manages the authorisation request and review process for the treatment of conditions identified in the Criteria for the clinical use of intravenous immunoglobulin in Australia.
Online version of the Criteria
An adaptation of the second edition of the Criteria has been included in BloodSTAR and is applicable for all states and territories except NSW from 2016. The Criteria as they appear in BloodSTAR (version 2.1) can be viewed here.
The inclusion of new ‘evidence items’ fields within the Criteria version 2.1 in BloodSTAR does not change the basis for approval of authorisation of Ig product.
What is BloodSTAR?
Moving or Travelling Patient Process during BloodSTAR Transition
For guidance when patients receiving immunoglobulin products travel or move between States and/or Territories where BloodSTAR may or may not have been implemented, please refer to the below document.
- Managing moving or travelling patients during BloodSTAR transition (pdf) (375.67 KB)
- Managing moving or travelling patients during BloodSTAR transition (docx) (501.78 KB)
BloodSTAR and BloodNet Downtime Process
Details in the documents below on the steps to undertake if BloodSTAR or BloodNet are unavailable
- BloodSTAR BloodNet Downtime Process (pdf) (351.81 KB)
- BloodSTAR BloodNet Downtime Process (docx) (148.03 KB)
- User Support Materials
- User Registration
- Facility Registration
- Who will access BloodSTAR
- What is the Facilities Administrator role
- Privacy Controls
To discuss BloodSTAR further, please don’t hesitate to contact the Blood Operations Centre on 13 000 BLOOD (13 000 25663) or email@example.com .